S100A5 and urinary bladder carcinoma: MTT cell viability assays revealed that knockdown (Figure S21A, Supporting Information) and overexpression (Figure S21B, Supporting Information) of S100A5 significantly inhibited and promoted the proliferation of bladder cancer cells, respectively.